Thrombin generation in chronic obstructive pulmonary disease: Dependence on plasma factor composition

Thrombosis Research

Volumn 128, Issue 4, 2011, Pages

  Undas, Anetta ^a,b   Jankowski, Milosz ^b   Kaczmarek, Przemysław ^b   Sladek, Krzysztof ^b   Brummel Ziedins, Kathleen ^c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

Coagulation factors; COPD; Thrombin

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; C REACTIVE PROTEIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN; INTERLEUKIN 6; PROTEIN C; PROTHROMBIN; THEOPHYLLINE; THROMBIN; TISSUE FACTOR PATHWAY INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; FEMALE; FIBRINOGEN BLOOD LEVEL; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING;

AGED; ANTITHROMBINS; BLOOD COAGULATION; BLOOD COAGULATION FACTOR INHIBITORS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; CASE-CONTROL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; KINETICS; LIPOPROTEINS; LUNG; MALE; MIDDLE AGED; PHENOTYPE; POLAND; PROTEIN C; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; THROMBIN; VITAL CAPACITY;

EID: 80053346660     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.05.004     Document Type: Article

References (23)

1. D.D. Sin, N.R. Anthonisen, J.B. Soriano, and A.G. Agusti Mortality in COPD: role of comorbidities Eur Respir J 28 2006 1245 1257 (Pubitemid 44883863)
2. N.R. Anthonisen, J.E. Connett, P.L. Enright, and J. Manfreda Lung Health Study Research Group. Hospitalizations and mortality in the Lung Health Study Am J Respir Crit Care Med 166 2002 333 339 (Pubitemid 34864422)
3. L. Huiart, P. Ernst, and S. Suissa Cardiovascular morbidity and mortality in COPD Chest 128 2005 2640 2646 (Pubitemid 41507622)
4. D.D. Sin, and S.F. Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 2003 1514 1519 (Pubitemid 36378490)
5. J. Ashitani, H. Mukae, Y. Arimura, and S. Matsukura Elevated plasma procoagulant and fibrinolytic markers in patients with chronic obstructive pulmonary disease Int Med 41 2002 181 185 (Pubitemid 34285434)
6. A. Undas, P. Kaczmarek, K. Sładek, E. Stepien, W. Skucha, and M. Rzeszutko Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment Thromb Haemost 102 2009 1176 1182
7. V.R. Vaidyula, G.J. Criner, C. Grabianowski, and A.K. Rao Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease Thromb Res 124 2009 259 261
8. M. Jankowski, A. Undas, P. Kaczmarek, and S. Butenas Activated factor XI and tissue factor in chronic obstructive pulmonary disease: links with inflammation and thrombin generation Thromb Res 127 2011 242 246
9. Global Initiative for Chronic Obstructive Lung Disease: Global strategy for diagnosis, management, and prevention of chronic obstructive pumonary disease www.goldcopd.com (updated 2010)
10. C. Alessandri, S. Basili, F. Violi, P. Ferroni, P.P. Gazzaniga, and C. Cordova Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group Thromb Haemost 72 1994 343 346 (Pubitemid 24280769)
11. K.E. Brummel-Ziedins, R.L. Pouliot, and K.G. Mann Thrombin generation: phenotypic quantitation J Thromb Haemost 2 2004 281 288 (Pubitemid 40186043)
12. K.E. Brummel-Ziedins, C.Y. Vossen, S. Butenas, K.G. Mann, and F.R. Rosendaal Thrombin generation profiles in deep venous thrombosis J Thromb Haemost 3 2005 2497 2505 (Pubitemid 41727167)
13. K. Brummel-Ziedins, A. Undas, T. Orfeo, and K.G. Mann Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition J Thromb Haemost 6 2008 104 110
14. A. Undas, M. Gissel, B. Kwasny-Krochin, P. Gluszko, and K. Brummel-Ziedins Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition Thromb Haemost 104 2010 224 230
15. S.M. Curkendall, C. DeLuise, J.K. Jones, S. Lanes, M.R. Stang, and E. Goehring Jr. Cardiovascular disease in patients with in chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients Ann Epidemiol 16 2006 63 70 (Pubitemid 41783891)
16. N. Mackman, R.E. Tilley, and N.S. Key Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis Arterioscler Thromb Vasc Biol 27 2007 1687 1693 (Pubitemid 47207163)
17. G. Cella, A. Sbarai, G. Mazzaro, B. Vanzo, S. Romano, and T. Hoppensteadt Plasma markers of endothelial dysfunction in chronic obstructive pulmonary disease Clin Appl Thromb Haemost 7 2001 205 208 (Pubitemid 32574181)
18. G. Cella, M. Saetta, S. Baraldo, G. Turato, A. Papi, and G. Casoni Endothelial cell activity in chronic obstructive pulmonary disease without severe pulmonary hypertension Clin Appl Thromb Haemost 11 2005 435 440 (Pubitemid 41546770)
19. R. Vormittag, P. Bencur, C. Ay, T. Tengler, T. Vukovich, and P. Quehenberger Low-density lipoprotein receptor-related protein 1 polymorphism 663 C > T affects clotting factor VIII activity and increases the risk of venous thromboembolism J Thromb Haemost 5 2007 497 502 (Pubitemid 46680681)
20. R. Sabit, P. Thomas, D.J. Shale, P. Collins, and S.J. Linnane The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD Chest 138 2010 47 51
21. B. van Zaane, E. Nur, A. Squizzato, V.E. Gerdes, H.R. Büller, and O.M. Dekkers Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors J Thromb Haemost 8 2010 2483 2493
22. A. Undas, R. Topor-Madry, and W. Tracz Simvastatin increases clot permeability and susceptibility to lysis in patients with LDL cholesterol below 3.4 mmol/l Pol Arch Med Wewn 119 2009 354 359
23. P. Kaczmarek, K. Sładek, W. Skucha, M. Rzeszutko, T. Iwaniec, and A. Szczeklik The influence of simvastatin on selected inflammatory markers in patients with chronic obstructive pulmonary disease Pol Arch Med Wewn 120 2010 11 17